1. Home
  2. RANI vs SCWO Comparison

RANI vs SCWO Comparison

Compare RANI & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • SCWO
  • Stock Information
  • Founded
  • RANI 2012
  • SCWO 2021
  • Country
  • RANI United States
  • SCWO United States
  • Employees
  • RANI 140
  • SCWO N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • SCWO Environmental Services
  • Sector
  • RANI Health Care
  • SCWO Utilities
  • Exchange
  • RANI Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • RANI 55.3M
  • SCWO 64.3M
  • IPO Year
  • RANI 2021
  • SCWO N/A
  • Fundamental
  • Price
  • RANI $1.66
  • SCWO $0.35
  • Analyst Decision
  • RANI Strong Buy
  • SCWO
  • Analyst Count
  • RANI 6
  • SCWO 0
  • Target Price
  • RANI $11.33
  • SCWO N/A
  • AVG Volume (30 Days)
  • RANI 2.3M
  • SCWO 328.2K
  • Earning Date
  • RANI 03-19-2025
  • SCWO 03-28-2025
  • Dividend Yield
  • RANI N/A
  • SCWO N/A
  • EPS Growth
  • RANI N/A
  • SCWO N/A
  • EPS
  • RANI N/A
  • SCWO N/A
  • Revenue
  • RANI N/A
  • SCWO $313,930.00
  • Revenue This Year
  • RANI N/A
  • SCWO N/A
  • Revenue Next Year
  • RANI N/A
  • SCWO $5,180.00
  • P/E Ratio
  • RANI N/A
  • SCWO N/A
  • Revenue Growth
  • RANI N/A
  • SCWO N/A
  • 52 Week Low
  • RANI $1.24
  • SCWO $0.30
  • 52 Week High
  • RANI $8.75
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • RANI 54.80
  • SCWO 28.13
  • Support Level
  • RANI $1.59
  • SCWO $0.35
  • Resistance Level
  • RANI $1.90
  • SCWO $0.58
  • Average True Range (ATR)
  • RANI 0.15
  • SCWO 0.05
  • MACD
  • RANI 0.03
  • SCWO 0.01
  • Stochastic Oscillator
  • RANI 56.36
  • SCWO 22.30

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: